Avior Wealth Management’s Adaptive Biotechnologies ADPT Stock Holding History

Avior Wealth Management’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$223K	Sell	10,408 -2,507	-19%	-$38.4K	0.01%	729
2026 Q1	$179K	Buy	12,915 +1,381	+12%	+$22K	0.01%	803
2025 Q4	$187K	Buy	+11,534	New	+$188K	0.01%	723
2024 Q2	–	Sell	-24	Closed	-$77	–	2275
2024 Q1	$77	Buy	+24	New	+$93	﹤0.01%	3295
2023 Q2	–	Sell	-300	Closed	-$2.23K	–	1562
2023 Q1	$2.65K	Buy	+300	New	+$2.65K	﹤0.01%	1362

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Avior Wealth Management's ADPT Position: Q2 2026 in Review

Avior Wealth Management reduced its Adaptive Biotechnologies (ADPT) stake by 19% in Q2 2026, selling an estimated $38.4K and leaving 10,408 shares worth $223K. The position accounts for 0.01% of the portfolio, ranked #729.

Avior Wealth Management first reported a position in ADPT in Q1 2023 and has held it in 5 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Avior Wealth Management held 10,408 shares of Adaptive Biotechnologies worth $223K as of Q2 2026.
Avior Wealth Management sold 2,507 Adaptive Biotechnologies shares in Q2 2026, an estimated $38.4K.
Adaptive Biotechnologies made up 0.01% of Avior Wealth Management's portfolio in Q2 2026, its #729 holding.
Avior Wealth Management first reported a position in Adaptive Biotechnologies in Q1 2023 and has held it in 5 quarters since.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.